TargED to Present First Clinical and New Preclinical Data on TGD001 at ASH 2025

We’re proud to announce that TargED will deliver two oral presentations at the ASH Annual Meeting 2025, sharing our first clinical data on the investigational thrombolytic fusion protein TGD001, alongside new preclinical results.